Skip to main content
Premium Trial:

Request an Annual Quote

John Stuelpnagel, John West, Christian Henry, Randy Hassler, Christopher Burton, John Bellano

John Stuelpnagel, Illumina’s senior VP, COO and GM for arrays, will shift to a part-time status in April and will give up his seat on the board of directors, although he will continue to work as an Illumina fellow, the firm said last week.
Illumina also said Senior VP and GM of Sequencing John West will resign his position as of Feb. 1, and current senior VP and CFO Christian Henry will become acting manager of sequencing.
The management changes were announced in conjunction with a reorganization of its business into two divisions, one focused on life sciences research and the other on diagnostics. The firm noted that it has already has hired two new general managers to oversee the divisions, but it has not disclosed their names.

The Seattle Biomedical Research Institute, which is establishing the Seattle Structural Genomics Center, has appointed Randy Hassler to be VP of operations and finance.
Hassler formerly was a VP of facility operations at Amgen and he has been a member of SBRI’s board of trustees for two years. He also was on the institute’s business strategy committee.

Third Wave Technologies announced the appointment of Christopher Burton as the company's senior vice president of sales and marketing. John Bellano, VP of sales, will continue to lead Third Wave's clinical sales and customer service teams in the Americas, the company announce this week.
Burton joins Third Wave from GE Healthcare, where most recently he was general manager of sales and marketing for the maternal and infant care unit. Prior to GE, Burton was a sales executive at Isotechnologies, a Hillsborough, NC-based diagnostic equipment manufacturer.

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.